​
​

Crinetics Pharmaceuticals (CRNX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Crinetics Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$4.01M

0

Crinetics Pharmaceuticals Revenue by Period

Crinetics Pharmaceuticals Revenue by Year

DateRevenueChange
2023-12-31$4.01M-15.28%
2022-12-31$4.74M339.42%
2021-12-31$1.08M1418.31%
2020-12-31$71.00K-94.05%
2019-12-31$1.19M-50.86%
2018-12-31$2.43M18.73%
2017-12-31$2.04M247.20%
2016-12-31$589.00K-

Crinetics Pharmaceuticals generated $4.01M in revenue during NA 2023, up -15.28% compared to the previous quarter, and up 165.28% compared to the same period a year ago.

Crinetics Pharmaceuticals Revenue by Quarter

DateRevenueChange
2024-09-30--100.00%
2024-06-30$399.00K-37.66%
2024-03-31$640.00K100.00%
2023-12-31--100.00%
2023-09-30$346.00K-64.98%
2023-06-30$988.00K-63.12%
2023-03-31$2.68M277.86%
2022-12-31$709.00K54.80%
2022-09-30$458.00K4.33%
2022-06-30$439.00K-85.98%
2022-03-31$3.13M190.45%
2021-12-31$1.08M100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30--100.00%
2020-03-31$71.00K-77.88%
2019-12-31$321.00K-36.44%
2019-09-30$505.00K100.00%
2019-06-30--100.00%
2019-03-31$367.00K-53.01%
2018-12-31$781.00K42.52%
2018-09-30$548.00K-16.59%
2018-06-30$657.00K48.64%
2018-03-31$442.00K-16.29%
2017-12-31$528.00K-17.50%
2017-09-30$640.00K-23.08%
2017-06-30$832.00K1748.89%
2017-03-31$45.00K-

Crinetics Pharmaceuticals generated - in revenue during Q3 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Crinetics Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ALECAlector$97.06M$15.08M
RGNXREGENXBIO$90.24M$24.20M
MRUSMerus$43.95M$11.77M
CYTKCytokinetics$7.53M$463.00K
KZRKezar Life Sciences$7.00M-
KRONKronos Bio$6.29M$2.37M
CRNXCrinetics Pharmaceuticals$4.01M-
INBXInhibrx Biosciences$1.80M-
VRDNViridian Therapeutics$314.00K$86.00K
LYELLyell Immunopharma$130.00K$34.00K
GPCRStructure Therapeutics--
LIANLianBio--
BDTXBlack Diamond Therapeutics--
PASGPassage Bio--

CRNX Revenue FAQ

What is Crinetics Pharmaceuticals’s yearly revenue?

Crinetics Pharmaceuticals's yearly revenue for 2023 was $4.01M, representing a decrease of -15.28% compared to 2022. The company's yearly revenue for 2022 was $4.74M, representing an increase of 339.42% compared to 2021. CRNX's yearly revenue for 2021 was $1.08M, representing an increase of 1418.31% compared to 2020.

What is Crinetics Pharmaceuticals’s quarterly revenue?

Crinetics Pharmaceuticals's quarterly revenue for Q3 2024 was $0, a -100.00% decrease from the previous quarter (Q2 2024), and a -100.00% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $399K, a -37.66% decrease from the previous quarter (Q1 2024), and a -59.62% decrease year-over-year (Q2 2023). CRNX's quarterly revenue for Q1 2024 was $640K, a 100.00% increase from the previous quarter (Q4 2023), and a -76.11% decrease year-over-year (Q1 2023).

What is Crinetics Pharmaceuticals’s revenue growth rate?

Crinetics Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 272.26%, and for the last 5 years (2019-2023) was 236.38%.